Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Irritable Bowel Syndrome (IBS) - Market Insight, Epidemiology, and Market Forecast - 2034
... syndrome were reported in the 7MM in 2023. The United States accounted for ~46% of the total 7MM prevalent cases. It has been observed that irritable bowel syndrome is more prevalent in younger ages ( ... Read More
-
Cardiovascular Drugs
... CAGR of 3.4% over the analysis period 2024-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$57.7 Billion by the end of the analysis period. ... Read More
-
Antibiotics
... 3.1% over the analysis period 2024-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth in ... Read More
-
Prostate Cancer Therapeutics
... at a CAGR of 6.6% over the analysis period 2024-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$21.0 Billion by the end of ... Read More
-
CNS Therapeutics
... CAGR of 7.3% over the analysis period 2024-2030. Neurodegenerative Diseases, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end of the analysis ... Read More
-
Cardiovascular Catheters
... CAGR of 6.6% over the analysis period 2024-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$25.4 Billion by the end of the ... Read More
-
Antidepressants
... 2.5% over the analysis period 2024-2030. Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end of the analysis period. ... Read More
-
Ovulation Test
... CAGR of 4.0% over the analysis period 2024-2030. Urine, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Angina Pectoris Drugs
... at a CAGR of 4.5% over the analysis period 2024-2030. Beta Blockers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.6 Billion by the end of ... Read More
-
Asthma Therapeutics
... CAGR of 2.3% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.7 Billion by the end of the analysis ... Read More
-
Bulk Paclitaxel
... CAGR of 8.5% over the analysis period 2024-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$139.1 Million by the end of the ... Read More
-
Cosmetic Procedures and Products
... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Facial Injectable, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.1 Billion by the ... Read More
-
Sexual Enhancers
... CAGR of 7.7% over the analysis period 2024-2030. Male Sexual Enhancers, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$354.9 Million by the end of the ... Read More
-
Sexual Wellness
... CAGR of 4.7% over the analysis period 2024-2030. Sex Toys, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$47.0 Billion by the end of the analysis ... Read More
-
Shoulder Arthroplasty
... CAGR of 4.1% over the analysis period 2024-2030. Partial, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.2 Billion by the end of the analysis period. ... Read More
-
Spinal Cord Trauma Treatment
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Surgery, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.7 Billion by the end ... Read More
-
Tobacco Alternative Gums
... at a CAGR of 6.0% over the analysis period 2024-2030. 2 mg, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Uterine Cancer Therapeutics and Diagnostics
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Endometrial Carcinomas, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion ... Read More
-
Short Bowel Syndrome (SBS)
... 2030, growing at a CAGR of 21.6% over the analysis period 2024-2030. GLP-2, one of the segments analyzed in the report, is expected to record a 23.2% CAGR and reach US$5.4 Billion by the end ... Read More
-
Substance Abuse Treatment
... at a CAGR of 7.2% over the analysis period 2024-2030. Nicotine Addiction Treatment, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$9.4 Billion by the end ... Read More
-
Ulcerative Colitis Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Oral, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.6 Billion by the end of the ... Read More
-
Sperm Banks
... CAGR of 5.3% over the analysis period 2024-2030. Sperm Storage, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the analysis ... Read More
-
Rare Endocrine Disease Treatment
... 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Acromegaly, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.7 Billion by the end ... Read More
-
Glioblastoma Multiforme Treatment (GBM)
... 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Radiation Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Extracorporeal CO2 Removal Devices
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by ... Read More
Research Assistance
